跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
高 崇蘭
教授
醫學系復健醫學科
h-index
h10-index
h5-index
3472
引文
35
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1124
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
435
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999
2024
每年研究成果
概覽
指紋
網路
研究成果
(121)
類似的個人檔案
(6)
指紋
查看啟用 Chung-Lan Kao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Sirtuin 1 (SIRT1)
100%
Exercise Training
68%
Benign Paroxysmal Positional Vertigo
59%
Resveratrol
59%
Dizziness
58%
Taiwan
56%
Artificial Intelligence
54%
Induced Pluripotent Stem Cells (iPSCs)
50%
Oxidative Stress
50%
Neural Stem Cells
48%
Hyaluronic Acid Injection
47%
Human Mesenchymal Stem Cells (hMSCs)
47%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
47%
Human Skeletal muscle
47%
Medulloblastoma
44%
Vestibular Rehabilitation
43%
Vestibular Hypofunction
41%
Cell-derived
39%
Electrical Stimulation
39%
Ginseng
38%
Diabetic Macular Edema
38%
Induced Apoptosis
38%
Balance Function
37%
Mesenchymal Stem Cells
36%
Skeletal muscle
35%
Nitric Oxide Level
35%
Chronic Dizziness
35%
CD133
35%
Eccentric Exercise
35%
Stem Cells
35%
B-cell Lymphoma 2 (Bcl-2)
34%
Bilateral Vestibular Hypofunction
33%
Dynamic Visual Acuity
32%
Neurodegenerative Diseases
29%
Optical Coherence Tomography
28%
Parkinson's Disease
28%
Nitric Oxide
28%
Insulin
28%
Osteoarthritis
27%
Phosphoinositide 3-kinase (PI3K)
27%
Quality of Life
27%
Exercise-induced
27%
Visual Analog Scale
27%
COVID-19
27%
Randomized Controlled Trial
26%
Older People
26%
Physical Therapy
26%
Adult Human Bone Marrow
25%
Insulin-producing Cells
24%
Rehabilitation Program
24%
Medicine and Dentistry
Apoplexy
69%
Skeletal Muscle
51%
Exercise
49%
Visual Acuity
47%
Restylane
47%
Diabetic Macular Edema
41%
Diseases
39%
Optical Coherence Tomography
39%
Dizziness
38%
Rehabilitation Engineering
35%
COVID-19
35%
Electrotherapy
35%
In Vitro
30%
Bilateral Vestibulopathy
29%
Diabetes Mellitus
29%
Stem Cell
27%
Knee Osteoarthritis
27%
Physiotherapy
26%
Neurorehabilitation
26%
Visual Analog Scale
26%
Induced Pluripotent Stem Cell
25%
Telemedicine
24%
Osteoarthritis
24%
Messenger RNA
24%
Neuroprotective Agent
23%
Gelatin
23%
Randomized Controlled Trial
23%
Galvanic Vestibular Stimulation
23%
Hypoxia
23%
Physical Rehabilitation
23%
Hematopoietic Cell
23%
Placebo
22%
Synovial Fluid
20%
Synovitis
20%
Western Ontario and McMaster Universities Osteoarthritis Index
20%
Oxidative Stress
20%
Supplementation
20%
Clinical Assessment
20%
Comorbidity
19%
Cell Signaling Pathway
18%
Human Umbilical Vein Endothelial Cell
18%
Combination Therapy
18%
Ex Vivo
18%
Neural Stem Cell
17%
Elderly Patient
17%
microRNA
17%
Protein Kinase B
16%
Obesity
16%
Somatomedin C
15%
Orthopedics
15%
